FR3027519B1 - USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN - Google Patents

USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN

Info

Publication number
FR3027519B1
FR3027519B1 FR1460255A FR1460255A FR3027519B1 FR 3027519 B1 FR3027519 B1 FR 3027519B1 FR 1460255 A FR1460255 A FR 1460255A FR 1460255 A FR1460255 A FR 1460255A FR 3027519 B1 FR3027519 B1 FR 3027519B1
Authority
FR
France
Prior art keywords
isosorbid
browning
esters
amino acids
human skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1460255A
Other languages
French (fr)
Other versions
FR3027519A1 (en
Inventor
Laetitia Cattuzzato
Sandy Dumont
Jerome Guilbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority to FR1460255A priority Critical patent/FR3027519B1/en
Publication of FR3027519A1 publication Critical patent/FR3027519A1/en
Application granted granted Critical
Publication of FR3027519B1 publication Critical patent/FR3027519B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
FR1460255A 2014-10-24 2014-10-24 USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN Active FR3027519B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1460255A FR3027519B1 (en) 2014-10-24 2014-10-24 USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1460255A FR3027519B1 (en) 2014-10-24 2014-10-24 USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN

Publications (2)

Publication Number Publication Date
FR3027519A1 FR3027519A1 (en) 2016-04-29
FR3027519B1 true FR3027519B1 (en) 2016-12-02

Family

ID=52102897

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1460255A Active FR3027519B1 (en) 2014-10-24 2014-10-24 USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN

Country Status (1)

Country Link
FR (1) FR3027519B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240139090A1 (en) * 2022-10-12 2024-05-02 The Procter & Gamble Company Cosmetic composition comprising polyacrylate crosspolymer-6 and high hlb nonionic surfactant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
FR2977252B1 (en) * 2011-06-30 2013-08-02 Seppic Sa NOVEL ESTERS OF N-ACYLATED AMINO ACID DERIVATIVES AND ISOSORBID, PROCESS FOR THEIR PREPARATION, AND USE IN COSMETICS AND AS MEDICAMENT

Also Published As

Publication number Publication date
FR3027519A1 (en) 2016-04-29

Similar Documents

Publication Publication Date Title
IL293809A (en) Systems and methods for cosmetic treatment of the skin using ultrasound
IL270320B (en) Cosmetic products for skin health and methods of using them
IL272300A (en) Mbacomtan for use in the treatment of heart muscle hypertrophy
EP3601285A4 (en) THERAPEUTIC AGENT FOR INHIBITION OF PHOSPHODIESTERASIS AND RELATED DISEASES
EP4230133C0 (en) CONTROLLED AND PRECISE TREATMENT OF CARDIAC TISSUE
EP3384055A4 (en) THERAPEUTIC TARGETS FOR CORRECTION OF HUMAN DYSTROPHIN GENE BY GENE EDITION AND METHODS OF USE
EP3541345A4 (en) COSMETIC APPEARANCE OF THE SKIN
IL258393B1 (en) Combined treatment using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint inhibitors
EP3331430A4 (en) DEVICES AND METHODS FOR CARPETOGRAPHY OF CARDIAC ARRHYTHMIA
EP2967836A4 (en) CRYOPRESERVATION OF VIABLE HUMAN SKIN SUBSTITUTES
EP3352771A4 (en) OMBILICAL TISSUE COMPOSITIONS AND METHODS OF USE
IL269083A (en) Methods for the prevention and treatment of heart diseases
FR3027518B1 (en) USE OF ISOSORBIDE ESTER AND N-ACYL DERIVATIVES OF AMINO ACIDS AS AN ANTI-AGING AGENT FOR HUMAN SKIN
EP3959213C0 (en) PYRIMIDINE-JAK INHIBITORS FOR THE TREATMENT OF SKIN DISEASES
EP3554310A4 (en) PACKAGED SKIN TREATMENT COMPOSITION AND METHOD
EP3256461C0 (en) UREA AND SULFONAMIDE DERIVATIVES AS HUMAN HELICASE DDX3 INHIBITORS FOR THE TREATMENT OF VIRUS DISEASES
EP3849591A4 (en) METHODS AND COMPOSITIONS FOR TREATING DISEASES OF THE SKIN
EP3488850A4 (en) INNOVATIVE USE OF GZD824 AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF FOR THE TREATMENT OF DISEASES
EP3302250A4 (en) NON-INVASIVE SYSTEM AND METHOD FOR SPATIAL LOCATION OF SPECIFIC ELECTROCARDIAC ELEMENTS
EP3576601A4 (en) DEVICES AND METHODS FOR IMAGING HEART TISSUE
EP3318613A4 (en) COATING AGENT AND SURFACE OF MEDICAL INSTRUMENT TREATED BY COATING AGENT
EP3681410A4 (en) HEART TREATMENT SYSTEM AND PROCEDURE
EP3436017A4 (en) PURIC INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE DELTA HUMAN
FR3027519B1 (en) USE OF ISOSORBID ESTERS AND N-ACYL DERIVATIVES OF AMINO ACIDS AS A BROWNING AND / OR TANNING AGENT FOR HUMAN SKIN
EP3619890A4 (en) SYSTEMS AND PROCEDURES TO DIFFERENTIATE BETWEEN HUMAN USERS AND SOFTWARE ROBOTS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160429

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12